alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
PROMISSORY
NOTE

     

    
      	
              Borrowers:

            	
              PRIME
      ACQUISITION CORP.,

            


    

    with a
Registered Office at:

    
      Codan
Trust Company (Cayman) Ltd..

    

    
      Cricket
Square, Hutchins Dr..

    

    
      PO box
2681,

    

    
      Grand
Cayman, KY1-11 11,

    

    
      Cayman
Islands

       

    

    
      	
              Lender:

            	
              Diana
      Liu

            


    

     

    FOR VALUE RECEIVED,
PRIME ACQUISITION CORP. promises to pay to Diana Liu at such address
as may be provided in writing to the Company, the principal sum of fifty
thousand ($50.000.00) USD. The principal pays no interest. Any unpaid principal
are to be paid in full on or before December 31st. 2010 or the date that the
Company’s F-1 filing becomes Effective, whichever date comes first.

     

    FORM OF PAYMENT. Any check.
draft, Money Order, or other instrument given in payment of all or any portion
hereof may be accepted by the holder and handled in collection in the customary
manner, but the same shall not constitute payment hereunder or diminish any
rights of the holder hereof except to the extent that actual cash proceeds of
such instruments are unconditionally received by the payee and applied to this
indebtedness in the manner elsewhere herein provided.

     

    BINDING EFFECT. The covenants,
obligations and conditions herein contained shall be binding on and inure to the
benefit of the heirs, legal representatives, and assigns of the parties
hereto.

     

    PLACE FOR PAYMENT. Borrower
promises to pay to the order of Payee at the place for payment and according to
the terms for payment the principal amount plus interest at the rates stated
above. All unpaid amounts shall be due by the final scheduled payment
date.

     

    GOVERNING LAW. This Note shall
be governed, construed and interpreted by, through and under the Laws of the
State of California.

     

    EXECUTED this 10th day of
FEBRUARY, 2010.

    


    
      
        
          
            	
                    /s/ William
      Yu                 

                  	 	
                    /s/ Diana Liu

                  
	 
      	 	 
      
	
                    Authorized
      Signatory

                    Prime
      Acquisition Corp.

                  	 	
                    Diana
      Liu
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Agriculture

###### Forest Service

# AGENCY:

Forest Service, USDA.

# ACTION:

Notice.

# SUMMARY:

On September 30, 2014 the Under Secretary of Natural Resources and Environment created the Current River Unit. This purchase unit comprises 1,868 acres within Ripley County, Missouri. A copy of the establishment document, which includes the legal description of the lands within the purchase unit, appears at the end of this notice.

# DATES:

The establishment of this purchase unit was effective September 30, 2014.

# ADDRESSES:

A copy of the map showing the purchase unit is on file and available for public inspection in the Office of the Director, Lands Staff, 1st Floor-Southeast, Sidney R. Yates Federal Building, Forest Service, USDA, 201 14th Street SW., Washington, DC 20250, between the hours of 8:30 a.m. and 4:30 p.m. on business days. Those wishing to inspect the map are encouraged to call ahead to (202) 205-1248 to facilitate entry into the building.

# FOR FURTHER INFORMATION CONTACT:

Gregory C. Smith, Director, Lands Staff, Forest Service, USDA, 1400 Independence Ave. SW., Mailstop 1124, Washington, DC 20250-0003, telephone: (202) 205-1248.

Individuals who use telecommunications devices for the deaf (TDD) may call the Federal Information Relay Service (FIRS) at 1-800-877-8339 between 8:00 a.m. and 8:00 p.m., Eastern Standard Time, Monday through Friday.

# SUPPLEMENTARY INFORMATION:

The Current River Purchase Unit will encompass mostly undeveloped lands adjacent to the Current River. The creation of this purchase unit allows for land acquisition of the remaining undeveloped parcels to protect the fragile Current River system and its many listed species. The Current River Purchase Unit will also provide protection and enhancement of watersheds and ecological communities, provide additional areas suitable for outdoor recreation, and provide public access to National Forest Lands.

Dated: January 20, 2015.

Gregory Smith,

Director of Lands and Realty Management.

      ( print page 4535)    

BILLING CODE 3411-15-P

[FR Doc. 2015-01474 Filed 1-27-15; 8:45 am]

BILLING CODE 3411-15-C
**Exhibit 31.1****CERTIFICATION**I, **Jeffrey A. Hawthorne**, certify that:1. I have reviewed this quarterly report on Form 10-Q of Photon Dynamics, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:     (a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating tothe registrant, including its consolidated subsidiaries, is made known to us by others withinthose entities, particularly during the period in which this report is being prepared;     (b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; and     (c) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (the registrant’sfourth fiscal quarter in the case of an annual report) that has materially affected, or isreasonably likely to materially affect, the registrant’s internal control over financialreporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of the registrant’s board of directors (or persons performing the equivalentfunctions):     (a) All significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and report financial information; and     (b) Any fraud, whether or not material, that involves management or other employees who havea significant role in the registrant’s internal control over financial reporting.     /s/ Jeffrey A. Hawthorne     **Jeffrey A. Hawthorne**  **President and Chief Executive Officer**   Date: August 9, 2005
HomeNRC LibraryDocument CollectionsNews Releases1997

# NRC Staff Sends Inspectors in Response to Broken Exit Sign at New Jersey Facility

----

----

I-97-142

October 30, 1997

NRC STAFF SENDS INSPECTORS IN RESPONSE TO BROKEN EXIT SIGN

AT NEW JERSEY FACILITY

The New Jersey Department of Environmental Protection has notified the Nuclear Regulatory Commission that a tritium exit sign was broken last night (10/29) by a patient at the Arthur Brisbane Child Treatment Center in Farmingdale, N.J., leading to precautionary evacuations at the facility.

The sign contained about 15 curies of tritium, a radioactive isotope that releases a relatively weak form of radiation. The material does not pose any immediate health hazard to residents or staff at the facility or members of the public.

Officials at the Center alerted the New Jersey DEP, which in turn contacted the NRC. Representatives from the DEP, NRC and the Department of Energy's Brookhaven National Laboratory have responded to the event, and are taking samples from the Center to determine the extent of contamination.

Urine samples are also being collected from any potentially exposed patients and staff members. Results are not expected to be available until at least Friday.

The NRC staff has dispatched two inspectors and a supervisor to the facility to assist the State as needed.

The Arthur Brisbane Child Treatment Center is one of seven psychiatric facilities operated by the State of New Jersey. Patients, who live at the facility, range in age from 11 to 17 years of age.

The sign is licensed by the NRC under a general license.

Page Last Reviewed/Updated Wednesday, March 24, 2021
Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Annual Report of MR3 Systems, Inc., on Form
10-KSB (the "Report") for the period ended December 31, 2002 as filed with the
Securities and Exchange Commission on the date hereof, each of the undersigned
officers of MR3 Systems, Inc., certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the
best of the undersigned's knowledge and belief:

         1.       The Report complies with the requirements of section 13(a) or
                  15(d) of the Securities Exchange Act of 1934; and

         2.       The information contained in the Report fairly presents, in
                  all material respects, the financial condition and result of
                  operations of the Company.


Date:  March 17, 2004                   /s/ BRADLEY N. ROTTER
                                        ---------------------------------
                                        Bradley N. Rotter
                                        Chief Executive Officer

Date:  March 17, 2004                   /s/ GARY K. ABREIM
                                        ---------------------------------
                                        Gary K. Abreim
                                        Chief Financial Officer
EXHIBIT 24.1

POWER OF ATTORNEY

Know all by these presents, that I, the undersigned, do hereby appoint Mike
Kinney and Robert E. Brummels, or either of them, as my attorney-in-fact with full power of substitution, to execute in their respective names, individually and in my capacity as director:

(i) the Annual Report on Form 10-K for the year ended December 31, 2007 (the 2007 Annual Report) of Husker Ag, LLC and any and all
amendments thereto, and to file the 2007 Annual Report, any and all such amendments, and exhibits and documents thereto required in connection therewith with the Securities and Exchange Commission and granting unto each attorney-in-fact and any
substitute, full power and authority to do and to perform each and every act and thing requisite and necessary to be done in connection therewith, as fully as I might or could do in person, hereby ratifying and confirming all that said
attorneys-in-fact and their substitutes may lawfully do or cause to be done by virtue hereof; and

(ii) the Rule 13e-3 Transaction
Statement Under Section 13(e) of the Securities Exchange Act of 1934 on Schedule 13E-3 (the Schedule 13E-3) of Husker Ag, LLC and any and all amendments thereto, and to file the Schedule 13E-3, any and all such amendments, and
exhibits and documents thereto required in connection therewith with the Securities and Exchange Commission and granting unto each attorney-in-fact and any substitute, full power and authority to do and to perform each and every act and thing
requisite and necessary to be done in connection therewith, as fully as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and their substitutes may lawfully do or cause to be done by virtue hereof.

IN WITNESS WHEREOF, I have hereunto set my hand this 24thday of March, 2008.



/s/ Leonard WostrelLeonard Wostrel




|                  |  |   |  |    
|----------------- |  | - |  | ---
|STATE OF NEBRASKA |  | ) |  |    
|                  |  | ) |  | ss.
|COUNTY OF PIERCE  |  | ) |  |    

On this 24thday of March, 2008, before me, a Notary public qualified for said County, personally came Leonard Wostrel, known to me to be the identical person who signed
the foregoing instrument and acknowledged the execution thereof to be his voluntary act and deed.



|       |  |  |  |  |  |                                 
|------ |  |  |  |  |  | --------------------------------
|       |  |  | 
|       |  |  |  |  |  | /s/ Kristine Wacker             
|{Seal} |  |  |  |  |  | Notary Public                   
|       |  |  | 
|       |  |  |  |  |  | My commission expires: 2-28-2010
<PAGE>

                                  EXHIBIT 99.1

                                  CERTIFICATION

        Pursuant to Section 906 of the Public Company Accounting Reform and
Investor Protection Act of 2002 (18 U.S.C. Section 1350, as adopted) (the
Sarbanes-Oxley Act of 2002), Joseph D. Keegan, Ph.D., the Chief Executive
Officer of Molecular Devices Corporation (the "Company"), and Timothy A.
Harkness, the Chief Financial Officer of the Company, each hereby certifies
that, to his knowledge:

1. The Company's Quarterly Report on Form 10-Q for the period ended June 30,
2002, to which this Certification is attached as Exhibit 99.1 (the "Periodic
Report"), fully complies with the requirements of Section 13(a) or Section 15(d)
of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Periodic Report fairly presents, in all
material respects, the financial condition of the Company at the end of the
periods covered by the Periodic Report and results of operations of the Company
for the periods covered by the Periodic Report.

This certification accompanies the Periodic Report pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002 and shall not be deemed "filed" by the Company
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

Dated:  August 14, 2002


/s/ JOSEPH D. KEEGAN                                 /s/ TIMOTHY A. HARKNESS
------------------------                             ---------------------------
Joseph D. Keegan, Ph.D.                              Timothy A. Harkness
Chief Executive Officer                              Chief Financial Officer
Exhibit 13
                                   ----------


    Certification Required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C.
                Section 1350 (as adopted pursuant to Section 906
                       of the Sarbanes-Oxley Act of 2002)


I, Lee Hartwell, as President, Chief Executive Officer & Chief Financial Officer
of Hemosol Inc. (the "Company"), certify, pursuant to 18 U.S.C. Section 1350 (as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), that to my
knowledge:

(1)        the accompanying Annual Report on Form 20-F of the Company for the
           fiscal year ended December 31, 2003 (the "Report"), filed with the
           U.S. Securities and Exchange Commission, fully complies with the
           requirements of Section 13(a) or 15(d) of the Securities Exchange Act
           of 1934, as amended; and

(2)        the information contained in the Report fairly presents, in all
           material respects, the financial condition and results of operations
           of the Company.



Dated:  June 30, 2004

                                     /s/ LEE HARTWELL
                                     ----------------------------------------
                                     Lee Hartwell
                                     President, Chief Executive Officer and
                                     Chief Financial Officer
#### S. W. FARBER, INC., Appellant, v. TEXAS INSTRUMENTS, INCORPORATED.

No. 15013.

United States Court of Appeals Third Circuit.

Argued April 1, 1965.

Decided April 20, 1965.

Hobart N. Durham, Morgan, Finnegan, Durham & Pine, New York City (Thomas N. O’Neill, Jr., Montgomery, McCracken, Walker & Rhoads, Philadelphia, Pa., John C. Vassil, New York City, Herbert L. Cobin, Wilmington, Del., on the brief), for appellant.

Robert F. Davis, Washington, D. C. (C. Edward Duffy, Wilmington, Del., Lloyd R. Koenig, Koenig, Senniger, Powers & Leavitt, St. Louis, Mo., Stevens, Davis, Miller & Mosher, Washington, D. C., S. M. Mims, Jr., Dallas, Tex., Townsend M. Gunn, Attleboro, Mass., on the brief), for appellee.

Before HASTIE and FREEDMAN, Circuit Judges, and WEBER, District Judge.

PER CURIAM:

This patent infringement suit, tried to a district judge sitting without a jury, resulted in a judgment on the merits for the defendant. The court found that the claimed invention consisted of mechanical improvements and adaptations *958of the prior art which would have been obvious at the time in question to a person of ordinary skill in the art. Accordingly, applying the test stated in section 103 of Title 35, U.S.C., the court held that the differences between the subject matter sought to be patented and the prior art were not patentable.

 The finding of obviousness is supported by affirmative testimony and cannot be characterized as unreasonable or unwarranted in the light of a record which discloses fully and with particularity the simple mechanical adaptations of familiar structures, directly indicated by the problem to be solved, which are the essence of the claimed invention.

The judgment will be affirmed on the proper findings and the logical and convincing analysis of the district court. 1964, 230 F.Supp. 883.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Drug Enforcement Administration

          - [Docket No. DEA-392]

# ACTION:

Notice of registration.

# SUMMARY:

Pharmacore, Inc. applied to be registered as a manufacturer of a basic class of controlled substance. The DEA grants Pharmacore, Inc. registration as a manufacturer of this controlled substance.

# SUPPLEMENTARY INFORMATION:

                    By notice dated May 28, 2014, and published in the                     **Federal Register**                     on June 3, 2014, 79 FR 31987, Pharmacore, Inc., 4180 Mendenhall Oaks Parkway, High Point, North Carolina 27265, applied to be registered as a manufacturer of a certain basic class of controlled substance. No comments or objections were submitted to this notice.                

The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Pharmacore, Inc. to manufacture this basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.

Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of Noroxymorphone (9668), a basic class of controlled substance listed in schedule II.

The company plans to manufacture the listed controlled substance as an active pharmaceutical ingredient (API) for clinical trials.

Dated: January 9, 2015.

Joseph T. Rannazzisi,

Deputy Assistant Administrator.

[FR Doc. 2015-01298 Filed 1-23-15; 8:45 am]

BILLING CODE P
HomeNRC LibraryDocument CollectionsNUREG-Series PublicationsPublications Resulting from International Agreements

# IBLOCA Analysis for Vandellòs-NPP Using RELAP5/MOD3.3. Sensitivity Calculations to EOP Actions (NUREG/IA-0497)

On this page:
        - Publication Information
        - Abstract

Download complete document
        - NUREG/IA-0497 (PDF – 977 KB)

## Publication Information

**Manuscript Completed:** January 2018**Date Published:** February 2019

**Prepared by:** M. Pérez-Ferrgut, J. Freixa, F. Reventós and I. Sol

Department of Physics Universitat Politècnica de Catalunya ETSEIB, Av. Diagonal 647, Pav. C 08028 Barcelona Spain 

Kirk Tien, NRC Project Manager

Division of Systems Analysis Office of Nuclear Regulatory Research U.S. Nuclear Regulatory Commission Washington, DC 20555-0001

**Prepared as part of:** The Agreement on Research Participation and Technical Exchange Under the Thermal-Hydraulic Code Applications and Maintenance Program (CAMP)

**Published by:** U.S. Nuclear Regulatory Commission Washington, DC 20555-0001 

Availability Notice

## Abstract

This report analyzes the effect of the plant specific EOPs for the RCPs during a hypothetical IBLOCA in Vandellòs II NPP, a 3 loop Westinghouse design reactor. The scenarios simulated are: 
        - Cold leg IBLOCA simulating the rupture of an accumulators connection to the RCS;
        - Hot leg IBLOCA simulating the rupture of the pressurizer surge line connection to the RCS.

The selection of an intermediate break size conforms to the risk-informed approach for the assessment of the ECCS performance.

The RELAP5/MOD3.3 model of Vandellòs II NPP was developed by the Advanced Nuclear Technologies (ANT) group at the Universitat Politècnica de Catalunya (UPC). 

Page Last Reviewed/Updated Tuesday, March 09, 2021
#### Ward W. MILLER, Trustee in Bankruptcy, petitioner, v. James Stewart Legare HAYNES, Sr.

No. 82-367.

Supreme Court of the United States.

Nov. 1, 1982.

Denied.